ARTICLE | Company News
Teva sales and marketing update
August 24, 2015 7:00 AM UTC
Teva launched 6.25 and 12.5 mg almotriptan tablets in the U.S. to treat migraines. The oral selective serotonin (5-HT1D) receptor agonist is a generic of Axert from Almirall S.A. (Madrid:ALM, Barce...